| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/20/2008 | WO2007146024A3 Cytomegalovirus surface protein complex for use in vaccines and as a drug target |
| 03/20/2008 | WO2007141043A3 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma |
| 03/20/2008 | WO2007140739A3 Apparatus and method for the subfractionation of an antibody mixed population directed against a polypeptide, together with plug-in mounting system |
| 03/20/2008 | WO2007134350A3 Antibodies specific for bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases |
| 03/20/2008 | WO2007127506A3 Anti-ephrinb2 antibodies and methods using same |
| 03/20/2008 | WO2007123771A3 Ige directed dna vaccination |
| 03/20/2008 | WO2007115829A3 Anti ku70 internalizing antibodies |
| 03/20/2008 | WO2007113648A3 Ctla4 antibody combination therapy |
| 03/20/2008 | WO2007106617A3 Method of treatment and prophylaxis of diseases related to amyloid deposition using igm |
| 03/20/2008 | WO2007092861A3 Inhibitors specific of presenilin-1 and their uses |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/20/2008 | US20080071064 Tempering |
| 03/20/2008 | US20080071063 Protein Formulations |
| 03/20/2008 | US20080071062 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity |
| 03/20/2008 | US20080070831 Endothelial growth factor; isolated polypeptide; stimulates cell proliferation, neovascularization, vascular system permeability; uses thereof in medical and diagnostic applications |
| 03/20/2008 | US20080070799 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 03/20/2008 | US20080070300 Human chemotactic cytokine |
| 03/20/2008 | US20080070291 Nucleotide sequences coding chlorophyllase for use in preparation of paper products, detergents and foods |
| 03/20/2008 | US20080070278 Immunoglobulin fusion comprising clostridial light chain for use in controlling interaction of particular cell types with their external environment; drug targeting and delivery |
| 03/20/2008 | US20080070268 Differential expression profiling analysis of cell culture phenotypes and the uses thereof |
| 03/20/2008 | US20080070265 Using immunoglobulins specific to apolipoproteins as diagnostic tool in detection of cardiovascular disorders |
| 03/20/2008 | US20080070259 Using presence or absence of mutation in metalloenzyme polynucleotides as diagnostic indicator of cardiovascular and neurodegenerative disorders |
| 03/20/2008 | US20080070255 Novel gene and uses therefor to modify pasture qualities of crops |
| 03/20/2008 | US20080069853 Sustained release of antibodies in milk; insertion of antigen releasing device in mammary glands lymph nodes |
| 03/20/2008 | US20080069839 Isolation and characterization of the precursor virus of human sars virus: sars-associated corona virus-like virus |
| 03/20/2008 | US20080069830 Isolation Dna; nucleotide sequences; genetic engineering |
| 03/20/2008 | US20080069829 Ability to bind to antibodies; diagnosis of allergies |
| 03/20/2008 | US20080069828 Detection of glandular disorders; bone disease ; calibrate different peptide fragments from whole parathyroid hormone; binding to antibody |
| 03/20/2008 | US20080069826 Novel Genes Associated with the Maintenance of Differentiation of Smooth Muscle Cells |
| 03/20/2008 | US20080069822 Immunoglobulins; cell line; screening; side effect reduction |
| 03/20/2008 | US20080069820 Mutations within light chain variable domain; antitumor agents |
| 03/20/2008 | US20080069816 Carcinoembryonic antigen (CEA); utilizes crystallographic structural data to select immunoglobulin framework having maximum structural overlap non-human donor molecule |
| 03/20/2008 | US20080069815 Autoimmune diseases; rheumatic arthritis |
| 03/20/2008 | US20080069813 Acid hydrolyzed IgG concentrate which prevents viral invasion |
| 03/20/2008 | US20080069777 Conformation Specific Antibodies |
| 03/20/2008 | US20080069775 Administering anti-idiotype antibody or antibody fragment comprising heavy chain variable region sequences and light chain variable region sequences conjugated to a soluble immunogenic carrier protein |
| 03/20/2008 | US20080069774 Targeting ligand specifically binding to an extracellular component of a cellular system, masking the extracellular component from interacting with a component of the cellular system; thrombotic occlusion and loss of vessel patency at the site of the vascular intervention |
| 03/20/2008 | US20080069770 Monoclonal antibodies; used to modulate the immune system; no modulation of the totality of the T-cell population but only of the sub-assembly of T-cells expressing the beta sub-family specific to the T-cell receptors; used for organ transplant rejection |
| 03/20/2008 | CA2664327A1 Method for detecting and treating skin disorders |
| 03/20/2008 | CA2662531A1 Treatment of multiple sclerosis (ms) with campath-1h |
| 03/20/2008 | CA2662005A1 Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma |
| 03/20/2008 | CA2642147A1 Influenza antibodies, compositions, and related methods |
| 03/19/2008 | EP1901070A2 Method and composition for detecting cancer by means of detection of Epstein-Barr virus nuclear antigen 2 coactivator p100 |
| 03/19/2008 | EP1901069A1 Fret protease assays for clostridial toxins |
| 03/19/2008 | EP1900818A2 Neisserial antigens |
| 03/19/2008 | EP1900816A2 GL50 molecules and uses therefor |
| 03/19/2008 | EP1900814A1 sc(Fv)2 SITE-DIRECTED MUTANT |
| 03/19/2008 | EP1900813A1 Novel physiological substance nesfatin, substance relevant thereto, and use of the substances |
| 03/19/2008 | EP1900811A1 Enriched central nervous system cell populations |
| 03/19/2008 | EP1900754A1 Fusion proteins comprising two lgG binding domains of streptococcal protein G |
| 03/19/2008 | EP1900753A2 Method of administering therapeutic polypeptides, and polypeptides therefor |
| 03/19/2008 | EP1900752A1 Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma |
| 03/19/2008 | EP1900751A1 Affinity purification of polypeptide on protein a matrix |
| 03/19/2008 | EP1900750A1 Fully human high yield production system for improved antibodies |
| 03/19/2008 | EP1900377A1 Inhibitors of GPR87 for cancer therapy |
| 03/19/2008 | EP1900376A2 Synergistic inhibition of HIV-1 fusion and attachment, compsitions and antobodies thereto |
| 03/19/2008 | EP1899477A2 An integrated approach for generating multidomain protein therapeutics |
| 03/19/2008 | EP1899464A2 Method of selecting polypeptides |
| 03/19/2008 | EP1899380A1 Idiotype vaccination with bispecific and multispecific immunoglobulin molecules |
| 03/19/2008 | EP1899379A2 Cd19 antibodies and their uses |
| 03/19/2008 | EP1899378A2 Il-1 beta binding antibodies and fragments thereof |
| 03/19/2008 | EP1899377A2 Humanised antibodies specific for nogo-a and phrarmaceutical uses thereof |
| 03/19/2008 | EP1899376A2 Antibodies against hmgb1 and fragments thereof |
| 03/19/2008 | EP1899367A1 Mutant allergen(s) |
| 03/19/2008 | EP1899366A2 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 03/19/2008 | EP1899364A2 Compositions and methods for immunomodulation in an organism |
| 03/19/2008 | EP1898943A2 Cxcr4 antagonists for wound healing and re-epithelialization |
| 03/19/2008 | EP1700916B1 Novel centromeric protein shugoshin |
| 03/19/2008 | EP1636354A4 Erk7 and erk8, novel diagnostic markers for cancer |
| 03/19/2008 | EP1428880B1 Kidney-specific urate transporter and gene thereof |
| 03/19/2008 | EP1145006B1 Detection of small molecules by use of a piezoelectric sensor |
| 03/19/2008 | EP1009831B1 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
| 03/19/2008 | CN101147063A 5-fluoro-uracil immunoassay |
| 03/19/2008 | CN101146909A Antigen binding molecules directed to MCSP and having increased Fc receptor binding affinity and effector function |
| 03/19/2008 | CN101146826A FC-fusion constructs binding to phosphatidylserine and their therapeutic use |
| 03/19/2008 | CN101146823A Molecules and chimeric molecules thereof |
| 03/19/2008 | CN101146553A Anti-CTLA4 antibody and indolinone combination therapy for treatment of cancer |
| 03/19/2008 | CN101146552A Therapy of prostate cancer with CTLA4 antibodies and hormonal therapy |
| 03/19/2008 | CN101144071A A strain of hybridoma capable of stably excreting anti-URG11 monoclonal antibody |
| 03/19/2008 | CN101143900A Method for producing recombination human ovary cancer anti-idiotype micro-antibody |
| 03/19/2008 | CN101143899A Isotope 188Re labeled monoclonal antibody and application thereof |
| 03/18/2008 | US7345156 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 03/18/2008 | US7345153 An antibody capable of specifically inhibiting the fusion of an HIV-1 envelope glycoprotein cell with a CD4+ cell without cross reacting with the HIV-1 envelope glycoprotein or CD4 and inhibits infection by strains of HIV-1 |
| 03/18/2008 | US7345152 Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency-encoded glycoprotein |
| 03/18/2008 | US7345151 Antagonists specific for denatured collagen and methods of using same |
| 03/18/2008 | US7345147 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 03/18/2008 | US7345146 PRO1271 Polypeptides |
| 03/18/2008 | US7344882 nucleotide sequences that code human transient receptor potential channel polypeptides or fragments; genetic vectors, host cells, antibodies, and recombinant and synthetic methods for producing polypeptides; drug screening; medical diagnosis |
| 03/18/2008 | US7344870 3-phosphoinositide-dependent protein kinase |
| 03/18/2008 | US7344862 Nucleotide sequences coding polypeptide for use ias diagnostic tool in genetic engineering; proteins that are colored and/or fluorescent, where this feature arises from the interaction of two or more residues of the protein |
| 03/18/2008 | US7344848 Using monoclonal antibodies to identify heat resistant protein in meat; screening meat source for exogenous meat samples; food safety and heat cooking |
| 03/18/2008 | US7344724 proteins and genes codes, used for medical diagnosis, screening biological targets and as vaccines against gramnegative bacterial infections |
| 03/18/2008 | US7344719 Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof |
| 03/18/2008 | US7344718 Yersinia species compositions |
| 03/18/2008 | US7344715 Method for treating multiple myeloma |
| 03/18/2008 | US7344714 Generation preferential antibody; construct peptide library, immunize cells, isolating and purify antisera from cells |
| 03/18/2008 | US7344713 Decreased fat absorption with an anti-lipase antibody |
| 03/18/2008 | CA2424977C Process for purifying antibody |
| 03/18/2008 | CA2185043C Monoclonal antibodies recognizing tie-receptor and their use |